The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Choroidal Neovascularization-Global Market Insights and Sales Trends 2024
Synopsis
Choroidal neovascularization describes the growth of new blood vessels that originate from the choroid through a break in the Bruch membrane into the sub–retinal pigment epithelium (sub-RPE) or subretinal space.
The global Choroidal Neovascularization market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Choroidal Neovascularization in various end use industries. The expanding demands from the Extreme Myopia, Malignant Myopic Degeneration and Age-Related Developments,, are propelling Choroidal Neovascularization market. Intravenous, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Intravitreal segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Choroidal Neovascularization, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Choroidal Neovascularization market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Choroidal Neovascularization market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Choroidal Neovascularization sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Choroidal Neovascularization covered in this report include Pfizer Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Regeneron Pharmaceuticals Inc., Bayer AG, QLT Inc., Sanwa Kagaku Kenkyusho Co. Ltd., Promedior Inc. and Bausch Health, etc.
The global Choroidal Neovascularization market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer Inc.
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
Bayer AG
QLT Inc.
Sanwa Kagaku Kenkyusho Co. Ltd.
Promedior Inc.
Bausch Health
Gilead Sciences Inc
Global Choroidal Neovascularization market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Choroidal Neovascularization market, Segment by Type:
Intravenous
Intravitreal
Global Choroidal Neovascularization market, by Application
Extreme Myopia
Malignant Myopic Degeneration
Age-Related Developments
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Choroidal Neovascularization manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Choroidal Neovascularization in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Choroidal neovascularization describes the growth of new blood vessels that originate from the choroid through a break in the Bruch membrane into the sub–retinal pigment epithelium (sub-RPE) or subretinal space.
The global Choroidal Neovascularization market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Choroidal Neovascularization in various end use industries. The expanding demands from the Extreme Myopia, Malignant Myopic Degeneration and Age-Related Developments,, are propelling Choroidal Neovascularization market. Intravenous, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Intravitreal segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Choroidal Neovascularization, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Choroidal Neovascularization market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Choroidal Neovascularization market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Choroidal Neovascularization sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Choroidal Neovascularization covered in this report include Pfizer Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Regeneron Pharmaceuticals Inc., Bayer AG, QLT Inc., Sanwa Kagaku Kenkyusho Co. Ltd., Promedior Inc. and Bausch Health, etc.
The global Choroidal Neovascularization market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer Inc.
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
Bayer AG
QLT Inc.
Sanwa Kagaku Kenkyusho Co. Ltd.
Promedior Inc.
Bausch Health
Gilead Sciences Inc
Global Choroidal Neovascularization market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Choroidal Neovascularization market, Segment by Type:
Intravenous
Intravitreal
Global Choroidal Neovascularization market, by Application
Extreme Myopia
Malignant Myopic Degeneration
Age-Related Developments
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Choroidal Neovascularization manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Choroidal Neovascularization in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Choroidal Neovascularization Market Overview
1.1 Choroidal Neovascularization Product Overview
1.2 Choroidal Neovascularization Market Segment by Type
1.2.1 Intravenous
1.2.2 Intravitreal
1.3 Global Choroidal Neovascularization Market Size by Type
1.3.1 Global Choroidal Neovascularization Market Size Overview by Type (2018-2029)
1.3.2 Global Choroidal Neovascularization Historic Market Size Review by Type (2018-2023)
1.3.3 Global Choroidal Neovascularization Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Choroidal Neovascularization Sales Breakdown by Type (2018-2023)
1.4.2 Europe Choroidal Neovascularization Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Choroidal Neovascularization Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Choroidal Neovascularization Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Choroidal Neovascularization Sales Breakdown by Type (2018-2023)
2 Global Choroidal Neovascularization Market Competition by Company
2.1 Global Top Players by Choroidal Neovascularization Sales (2018-2023)
2.2 Global Top Players by Choroidal Neovascularization Revenue (2018-2023)
2.3 Global Top Players by Choroidal Neovascularization Price (2018-2023)
2.4 Global Top Manufacturers Choroidal Neovascularization Manufacturing Base Distribution, Sales Area, Product Type
2.5 Choroidal Neovascularization Market Competitive Situation and Trends
2.5.1 Choroidal Neovascularization Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Choroidal Neovascularization Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Choroidal Neovascularization as of 2022)
2.7 Date of Key Manufacturers Enter into Choroidal Neovascularization Market
2.8 Key Manufacturers Choroidal Neovascularization Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Choroidal Neovascularization Status and Outlook by Region
3.1 Global Choroidal Neovascularization Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Choroidal Neovascularization Historic Market Size by Region
3.2.1 Global Choroidal Neovascularization Sales in Volume by Region (2018-2023)
3.2.2 Global Choroidal Neovascularization Sales in Value by Region (2018-2023)
3.2.3 Global Choroidal Neovascularization Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Choroidal Neovascularization Forecasted Market Size by Region
3.3.1 Global Choroidal Neovascularization Sales in Volume by Region (2024-2029)
3.3.2 Global Choroidal Neovascularization Sales in Value by Region (2024-2029)
3.3.3 Global Choroidal Neovascularization Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Choroidal Neovascularization by Application
4.1 Choroidal Neovascularization Market Segment by Application
4.1.1 Extreme Myopia
4.1.2 Malignant Myopic Degeneration
4.1.3 Age-Related Developments
4.2 Global Choroidal Neovascularization Market Size by Application
4.2.1 Global Choroidal Neovascularization Market Size Overview by Application (2018-2029)
4.2.2 Global Choroidal Neovascularization Historic Market Size Review by Application (2018-2023)
4.2.3 Global Choroidal Neovascularization Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Choroidal Neovascularization Sales Breakdown by Application (2018-2023)
4.3.2 Europe Choroidal Neovascularization Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Choroidal Neovascularization Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Choroidal Neovascularization Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Choroidal Neovascularization Sales Breakdown by Application (2018-2023)
5 North America Choroidal Neovascularization by Country
5.1 North America Choroidal Neovascularization Historic Market Size by Country
5.1.1 North America Choroidal Neovascularization Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Choroidal Neovascularization Sales in Volume by Country (2018-2023)
5.1.3 North America Choroidal Neovascularization Sales in Value by Country (2018-2023)
5.2 North America Choroidal Neovascularization Forecasted Market Size by Country
5.2.1 North America Choroidal Neovascularization Sales in Volume by Country (2024-2029)
5.2.2 North America Choroidal Neovascularization Sales in Value by Country (2024-2029)
6 Europe Choroidal Neovascularization by Country
6.1 Europe Choroidal Neovascularization Historic Market Size by Country
6.1.1 Europe Choroidal Neovascularization Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Choroidal Neovascularization Sales in Volume by Country (2018-2023)
6.1.3 Europe Choroidal Neovascularization Sales in Value by Country (2018-2023)
6.2 Europe Choroidal Neovascularization Forecasted Market Size by Country
6.2.1 Europe Choroidal Neovascularization Sales in Volume by Country (2024-2029)
6.2.2 Europe Choroidal Neovascularization Sales in Value by Country (2024-2029)
7 Asia-Pacific Choroidal Neovascularization by Region
7.1 Asia-Pacific Choroidal Neovascularization Historic Market Size by Region
7.1.1 Asia-Pacific Choroidal Neovascularization Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Choroidal Neovascularization Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Choroidal Neovascularization Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Choroidal Neovascularization Forecasted Market Size by Region
7.2.1 Asia-Pacific Choroidal Neovascularization Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Choroidal Neovascularization Sales in Value by Region (2024-2029)
8 Latin America Choroidal Neovascularization by Country
8.1 Latin America Choroidal Neovascularization Historic Market Size by Country
8.1.1 Latin America Choroidal Neovascularization Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Choroidal Neovascularization Sales in Volume by Country (2018-2023)
8.1.3 Latin America Choroidal Neovascularization Sales in Value by Country (2018-2023)
8.2 Latin America Choroidal Neovascularization Forecasted Market Size by Country
8.2.1 Latin America Choroidal Neovascularization Sales in Volume by Country (2024-2029)
8.2.2 Latin America Choroidal Neovascularization Sales in Value by Country (2024-2029)
9 Middle East and Africa Choroidal Neovascularization by Country
9.1 Middle East and Africa Choroidal Neovascularization Historic Market Size by Country
9.1.1 Middle East and Africa Choroidal Neovascularization Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Choroidal Neovascularization Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Choroidal Neovascularization Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Choroidal Neovascularization Forecasted Market Size by Country
9.2.1 Middle East and Africa Choroidal Neovascularization Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Choroidal Neovascularization Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer Inc.
10.1.1 Pfizer Inc. Company Information
10.1.2 Pfizer Inc. Introduction and Business Overview
10.1.3 Pfizer Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Inc. Choroidal Neovascularization Products Offered
10.1.5 Pfizer Inc. Recent Development
10.2 F. Hoffmann-La Roche Ltd.
10.2.1 F. Hoffmann-La Roche Ltd. Company Information
10.2.2 F. Hoffmann-La Roche Ltd. Introduction and Business Overview
10.2.3 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales, Revenue and Gross Margin (2018-2023)
10.2.4 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Products Offered
10.2.5 F. Hoffmann-La Roche Ltd. Recent Development
10.3 Novartis AG
10.3.1 Novartis AG Company Information
10.3.2 Novartis AG Introduction and Business Overview
10.3.3 Novartis AG Choroidal Neovascularization Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Novartis AG Choroidal Neovascularization Products Offered
10.3.5 Novartis AG Recent Development
10.4 Regeneron Pharmaceuticals Inc.
10.4.1 Regeneron Pharmaceuticals Inc. Company Information
10.4.2 Regeneron Pharmaceuticals Inc. Introduction and Business Overview
10.4.3 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Products Offered
10.4.5 Regeneron Pharmaceuticals Inc. Recent Development
10.5 Bayer AG
10.5.1 Bayer AG Company Information
10.5.2 Bayer AG Introduction and Business Overview
10.5.3 Bayer AG Choroidal Neovascularization Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Bayer AG Choroidal Neovascularization Products Offered
10.5.5 Bayer AG Recent Development
10.6 QLT Inc.
10.6.1 QLT Inc. Company Information
10.6.2 QLT Inc. Introduction and Business Overview
10.6.3 QLT Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2018-2023)
10.6.4 QLT Inc. Choroidal Neovascularization Products Offered
10.6.5 QLT Inc. Recent Development
10.7 Sanwa Kagaku Kenkyusho Co. Ltd.
10.7.1 Sanwa Kagaku Kenkyusho Co. Ltd. Company Information
10.7.2 Sanwa Kagaku Kenkyusho Co. Ltd. Introduction and Business Overview
10.7.3 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Products Offered
10.7.5 Sanwa Kagaku Kenkyusho Co. Ltd. Recent Development
10.8 Promedior Inc.
10.8.1 Promedior Inc. Company Information
10.8.2 Promedior Inc. Introduction and Business Overview
10.8.3 Promedior Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Promedior Inc. Choroidal Neovascularization Products Offered
10.8.5 Promedior Inc. Recent Development
10.9 Bausch Health
10.9.1 Bausch Health Company Information
10.9.2 Bausch Health Introduction and Business Overview
10.9.3 Bausch Health Choroidal Neovascularization Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Bausch Health Choroidal Neovascularization Products Offered
10.9.5 Bausch Health Recent Development
10.10 Gilead Sciences Inc
10.10.1 Gilead Sciences Inc Company Information
10.10.2 Gilead Sciences Inc Introduction and Business Overview
10.10.3 Gilead Sciences Inc Choroidal Neovascularization Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Gilead Sciences Inc Choroidal Neovascularization Products Offered
10.10.5 Gilead Sciences Inc Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Choroidal Neovascularization Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Choroidal Neovascularization Industrial Chain Analysis
11.4 Choroidal Neovascularization Market Dynamics
11.4.1 Choroidal Neovascularization Industry Trends
11.4.2 Choroidal Neovascularization Market Drivers
11.4.3 Choroidal Neovascularization Market Challenges
11.4.4 Choroidal Neovascularization Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Choroidal Neovascularization Distributors
12.3 Choroidal Neovascularization Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
